For Its Blood Test to Detect Early-stage Prostate Cancer, Mumbai-based Datar Cancer Genetics Gets 'Breakthrough Designation' from the US FDA
Representational Image The US FDA grants the coveted Breakthrough Designation for Early-Stage Prost…
Representational Image The US FDA grants the coveted Breakthrough Designation for Early-Stage Prost…
Mestastop aims to make a difference by understanding metastasis biology and addressing it, for both…
ESMO, the leading organisation for medical oncology, has launched an important new service for rapi…